Navigation Links
Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors
Date:2/15/2011

he Parkinson's brains versus that seen in nonhuman primates, including contemporary models of Parkinson's disease.  In Parkinson's brains and in nonhuman primate brains, CERE-120 resulted in comparable NRTN expression in the targeted putamen, where the degenerating nerve terminals reside. However, in the case of Parkinson's disease, very little NRTN was seen in the cell bodies of the same degenerating neurons, which are located in a different brain region, called the substantia nigra.

Dr. Bartus stated, "These data warned us of a fundamental deficiency in Parkinson's disease brains which limits how effectively NRTN is transported from the terminals of degenerating neurons to their cell bodies.  This provided the key insight we needed to appreciate the need to directly inject CERE-120 into the substantia nigra (thus reducing dependency on retrograde transport), in addition to injecting a larger dose into the putamen.  These dosing changes are intended to help assure that the entire degenerating neuron is exposed to sufficient neurotrophic factor, assuring that a more robust neurotrophic response is stimulated, in turn, further enhancing and accelerating neuronal repair."  In June 2010, Ceregene announced that it had successfully completed a new Phase 1 study in Parkinson's patients, intended to provide initial evidence for the safety of this novel dosing paradigm.

Other authors of the paper include Christopher Herzog, Alistair Wilson, Lamar Brown and Joao Siffert (Ceregene, San Diego, CA), Y. Chu, Elliot Mufson and Jeffrey Kordower (Rush University Medical Center, Chicago, IL), Eugene Johnson, Jr. (Washington University, St Louis, MO) and C. Warren Olanow (Mt. Sinai School of Medicine, New York City).

About CERE-120 and its Application to Treating Parkinson's Disease

CERE-120 is composed of an adeno-associated virus (AAV) vector carrying the gene for neurturin, a naturally occurring protein known to repa
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
2. Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinsons Disease
3. SeraCare Reports First Quarter Fiscal Year 2011 Results
4. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
5. YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
6. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results
7. ERT Reports Fourth Quarter and Full Year 2010 Operating Results on March 1, 2011
8. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
9. Pharmacyclics Reports Recent Developments and Financial Results for Fiscal Second Quarter 2011
10. Codexis Reports Fourth Quarter and Full Year 2010 Results
11. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... “Preparative & Process Chromatography Market by ... Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, End ... to 2019” provides a detailed overview of the ... and strategies impacting the preparative and process chromatography ... the revenue and share analysis. , Full ...
(Date:12/24/2014)... Island, New York (PRWEB) December 23, 2014 ... and the Long Island Affiliate of ITRA Global, the national ... slow but steady recovery. This is evidenced by the ... the strong stock market. Low energy costs have held ... The only negative is the housing market remaining soft. ...
(Date:12/24/2014)... 2014 China Biologic Products, Inc. (NASDAQ: ... fully integrated plasma-based biopharmaceutical company in ... subsidiary, Shandong Taibang Biological Products Co. Ltd., has ... China Food and Drug Administration (the "CFDA") for ... disclosed in the Company,s public filings, the CFDA ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
Breaking Biology Technology:Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3
... LifeQuest World Corporation,(OTC Bulletin Board: LQWC) is ... work, ImmunXT, their Immune System enhancement supplement, has,been ... as of March 2008.,ImmunXT has been proclaimed as ... ImmunXT (US Patent #7,205,284 B2),is a bio-active Micro-algae ...
... (OTC Bulletin Board: GNTA) announced today that it ... (FINRA, formerly,the NASD) has cleared a market maker,s ... the Over-the-Counter Bulletin Board (OTCBB). As a,result, the ... Company,s,common stock will begin on Wednesday, May 7, ...
... Calif., May 6 Kosan Biosciences,Incorporated (Nasdaq: ... Vice,President, Corporate Communications, will present at the Leerink ... the Grand Hyatt Hotel on,Friday, May 9, 2008 ... the presentation,can be accessed through http://www.wsw.com/webcast/leerink15/kosn/ ., ...
Cached Biology Technology:LifeQuest World Launches Immune System Boosting Supplement to the North American Market 2Genta Announces Transfer of its Common Stock to the OTC Bulletin Board 2Genta Announces Transfer of its Common Stock to the OTC Bulletin Board 3Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference 2
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... gene therapy reversed course of disease in mouse modelsIn ... disease, scientists were able to reverse the rodents' memory ... is crucial for the development of Alzheimer's disease. , ... that stopping the synthesis of a protein that is ...
... Billions of people tuned into recent Live 8 concert ... the altruistic cause spearheaded by former Boomtown Rat, Sir ... of us look out for each other, while others ... natural selection has designed individuals to behave selfishishly; selfish ...
... medically important fungus, causing potentially life-threatening infections in patients ... cause of respiratory allergy, and it is implicated in ... to lack the ability to reproduce sexually, but new ... the fungus has a number of characteristics of sex. ...
Cached Biology News:Targeting a key enzyme with gene therapy reversed course of Alzheimer's disease in mouse models 2Targeting a key enzyme with gene therapy reversed course of Alzheimer's disease in mouse models 3Helping in a selfish world 2Secret sex life of killer fungus? 2
Recombinant Rat Leptin, CF...
2,4,6-Trinitrophenyl hapten is conjugated to Bovine Gamma Globulin (BGG) through lysine by amide bonds....
... 25 mL pipets ,Angled acrylic pipet rack offers ... or round pipet cans. Constructed of 6 mm (1/4 ... W x 76 mm H x 289 mm D ... 89 mm W x 406 mm H x 292 ...
... Contact Printing Kit contains choice of PDMS ... of 100 / 200 micron squares or ... um x 10 mm lines, 3 PDMS ... or 60 nm and pitch of 400 ...
Biology Products: